Nitrosamine risks that may arise from the filters
|
|
2
|
795
|
January 4, 2023
|
Calcium Phosphate- Opadry-Lhasa
|
|
0
|
418
|
December 21, 2022
|
E&L challenges and pitfalls in connection with NAs & NDRSIs
|
|
0
|
367
|
December 12, 2022
|
Drug-Nitrite interaction products -Publication review
|
|
2
|
678
|
November 30, 2022
|
Nitrocellulose blister material as a source of N-nitrosamine (peer-review-article)
|
|
2
|
1197
|
September 1, 2022
|
API seem to form N-nitrosamines upon oxidation (e.g. air) and without the presence of nitrosonium ions
|
|
1
|
673
|
August 4, 2022
|
Exact Root causes for NDMA in Metformin & NDSRI's Impurities in Varenicline, Quinapril & Orphenadrine
|
|
4
|
1033
|
July 7, 2022
|
Nitrosamines in Carbamazepine?
|
|
4
|
713
|
July 1, 2022
|
Risk of Nitrosamine Formation from Nitrites in Aqueous Systems
|
|
0
|
648
|
June 27, 2022
|
A Nitrite Excipient Database - Risk Assessment
|
|
6
|
1766
|
June 15, 2022
|
Drug substance-related impurities (NDSRIs) in Drug product and Drug substances
|
|
7
|
2899
|
June 8, 2022
|
Anybody dealing with Nitrosopiparazines?
|
|
1
|
432
|
June 7, 2022
|
FDA Root Causes of Nitrosamines Formation Fellowship
|
|
0
|
305
|
April 14, 2022
|
Risk of Nitrosamine in packaging materials, risk or control?
|
|
2
|
1586
|
April 1, 2022
|
NDMA in German Beer - A success Story
|
|
1
|
332
|
January 25, 2022
|
Testing and controls for nitrosamines for components of container closure systems
|
|
16
|
1607
|
November 29, 2021
|
Excipients, morpholine?
|
|
4
|
367
|
October 18, 2021
|
Nitrosamines - Elastomers perspective (PDA publication)
|
|
8
|
683
|
October 16, 2021
|
Results from survey on Nitrosamines in Excipients -Any thoughts?
|
|
10
|
763
|
September 23, 2021
|
Excipient & Nitrosamines -Q&A session
|
|
0
|
327
|
September 16, 2021
|
Challenges for API Raw Material & DP regarding Excipient / APIs / Packaging?
|
|
12
|
1380
|
August 17, 2021
|
Many excipientsuppliers are using the IPEC Questionnaire for Excipient Nitrosamine Risk Evaluation to conduct nitrosamine risk assessments. Does FDA accept prepared questionnaires,such as the one developed by IPEC, as a valid risk assessment tool?
|
|
0
|
380
|
July 20, 2021
|
Developing Process for Nitrite-free Excipients?
|
|
1
|
514
|
July 11, 2021
|
Most burning challenge for API manufacturers?
|
|
12
|
876
|
July 9, 2021
|
Are we ready to inlcude Nitrosamine testing on Inhalation Packaging/Delivery systems? USP: Nitrosamines in Elastomeric Components for Inhalation
|
|
0
|
351
|
April 27, 2021
|